IKB Invest Mergers & Acquisitions

IKB Invest M&A Summary

The Firm’s most common exit type is trade sale (34%).

Sign-up to view IKB Invest’s full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity1
    • M&A Sell Activity3
  • M&A Buy/Sell Connections2

IKB Invest GmbH

Dusseldorf, 40474
Germany
www.ikb-invest.de
invest@ikb.de

All (4) Buy (1) Sell (3)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2015-05-27 CellGenix · Life Science
Freiburg, Germany · www.cellgenix.com

CellGenix is a biopharmaceutical company active in the field of cellular therapies and regenerative medicine. The Company develops, manufactures and markets cell therapy products and high-quality reagents for ex vivo cell culture. CellGenix is a leading supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications worldwide. CellGenix was founded in 1994 and is located in Freiburg, Germany.

- Stake Sale -

IKB Invest GmbH PE

-

Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.